Total Payments
$7,174
2024 Payments
$1,396
Companies
56
Transactions
468
Medicare Patients
2,032
Medicare Billing
$314,011
Payment Breakdown by Category
Food & Beverage$7,155 (99.7%)
Education$18.61 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,155 | 465 | 99.7% |
| Education | $18.61 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,037 | 80 | $0 (2024) |
| Amgen Inc. | $833.16 | 54 | $0 (2024) |
| Novo Nordisk Inc | $557.91 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $477.89 | 39 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $314.84 | 14 | $0 (2024) |
| PFIZER INC. | $302.60 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $294.81 | 17 | $0 (2024) |
| Lilly USA, LLC | $285.95 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $255.99 | 16 | $0 (2024) |
| Allergan, Inc. | $229.54 | 15 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,396 | 72 | ABBVIE INC. ($260.12) |
| 2023 | $1,311 | 76 | ABBVIE INC. ($328.21) |
| 2022 | $994.85 | 66 | ABBVIE INC. ($205.82) |
| 2021 | $1,181 | 82 | AbbVie Inc. ($210.03) |
| 2020 | $663.51 | 48 | Amgen Inc. ($143.89) |
| 2019 | $483.30 | 40 | Amgen Inc. ($119.23) |
| 2018 | $520.49 | 38 | Janssen Pharmaceuticals, Inc ($77.39) |
| 2017 | $623.99 | 46 | Janssen Pharmaceuticals, Inc ($105.06) |
All Payment Transactions
468 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Diabetes Care | ||||||
| 12/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Obesity | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: VACCINE | ||||||
| 11/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Obesity | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $0.30 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Hepatitis B Vaccine | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: DIABETES | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardio-renal | ||||||
| 08/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: DIABETES | ||||||
| 08/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Oncology | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 516 | 1,337 | $114,934 | $64,780 |
| 2022 | 10 | 437 | 933 | $98,238 | $55,574 |
| 2021 | 11 | 399 | 1,215 | $134,090 | $76,629 |
| 2020 | 14 | 680 | 1,903 | $204,746 | $117,029 |
Total Patients
2,032
Total Services
5,388
Medicare Billing
$314,011
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 52 | 595 | $35,971 | $23,288 | 64.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 218 | $35,760 | $16,795 | 47.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 68 | 68 | $15,736 | $8,494 | 54.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 86 | $8,801 | $5,342 | 60.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $4,393 | $2,405 | 54.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 32 | 32 | $3,700 | $2,094 | 56.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 29 | $3,280 | $1,684 | 51.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 23 | $1,951 | $1,651 | 84.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 49 | 114 | $1,938 | $1,060 | 54.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 27 | $804.00 | $773.02 | 96.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 63 | 63 | $1,221 | $632.42 | 51.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 32 | $896.00 | $335.14 | 37.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 12 | 23 | $161.00 | $115.29 | 71.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $322.00 | $111.10 | 34.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 425 | $38,675 | $23,513 | 60.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 159 | $25,440 | $12,734 | 50.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $11,730 | $6,445 | 54.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 70 | $7,700 | $4,040 | 52.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $5,292 | $3,092 | 58.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 27 | 27 | $2,154 | $1,841 | 85.5% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 26 | 26 | $3,094 | $1,356 | 43.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 68 | 68 | $2,079 | $1,107 | 53.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $1,190 | $947.93 | 79.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 35 | 52 | $884.00 | $497.54 | 56.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 38 | 688 | $61,995 | $39,015 | 62.9% |
About Dr. Anthony Meier, MD
Dr. Anthony Meier, MD is a Internal Medicine healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134236268.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Meier, MD has received a total of $7,174 in payments from pharmaceutical and medical device companies, with $1,396 received in 2024. These payments were reported across 468 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($7,155).
As a Medicare-enrolled provider, Meier has provided services to 2,032 Medicare beneficiaries, totaling 5,388 services with total Medicare billing of $314,011. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lansing, MI
- Active Since 08/24/2006
- Last Updated 03/19/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134236268
Products in Payments
- UBRELVY (Drug) $460.08
- VRAYLAR (Drug) $453.50
- XARELTO (Drug) $375.78
- Aimovig (Biological) $354.88
- REXULTI (Drug) $314.84
- Ozempic (Drug) $302.14
- Otezla (Drug) $205.08
- TRELEGY ELLIPTA (Drug) $178.70
- NURTEC ODT (Drug) $176.76
- Kerendia (Drug) $167.88
- EVENITY (Biological) $162.32
- ENTRESTO (Drug) $152.29
- AIRSUPRA (Drug) $135.84
- ELIQUIS (Drug) $130.07
- QULIPTA (Drug) $129.50
- JARDIANCE (Drug) $121.01
- TRULICITY (Drug) $119.11
- AREXVY (Drug) $105.74
- Vascepa (Drug) $102.94
- DALVANCE (Drug) $98.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lansing
Dr. Peter Gulick, D.o, D.O
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Joshua June, Do, DO
Internal Medicine — Payments: $456,912
Internal Medicine $456,912
Dr. Kara Hoisington
Internal Medicine — Payments: $303,208
Internal Medicine $303,208
Chris Farnum, Do, DO
Internal Medicine — Payments: $117,503
Internal Medicine $117,503
Miki Yokokawa, Md, MD
Internal Medicine — Payments: $84,271
Internal Medicine $84,271
Dr. Khader Herzallah, Md, MD
Internal Medicine — Payments: $48,157
Internal Medicine $48,157